Venlafaxine Hydrochloride
Product Images NDC 50090-3084

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-3084). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (A7f843b6 0935 4be6 A465 97179a846148 01)

A chart depicting drug interaction effects on venlafaxine pharmacokinetics, showing fold change and 90% confidence intervals for various interacting drugs including ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The chart includes recommendations for use based on these interactions, such as avoiding concomitant use or exercising caution in specific patient populations.*

FDA Label Image

Figure 2 (A7f843b6 0935 4be6 A465 97179a846148 02)

A pharmacokinetic chart depicting fold changes in Cmax and AUC for various interacting drugs and their analytes relative to a reference for VENLAFAXINE HYDROCHLORIDE. Each drug and metabolite is listed on the left, with corresponding fold change data points and 90% confidence intervals plotted on the horizontal axis, ranging from 0 to 3. Recommendations on dose adjustment or clinical significance accompany the data.*

FDA Label Image

Figure 3 (A7f843b6 0935 4be6 A465 97179a846148 03)

A chart showing fold change and 90% confidence intervals of venlafaxine and its ODV metabolite pharmacokinetic parameters (Cmax and AUC) across special populations. It includes hepatic impairment (cirrhosis, mild, moderate), renal impairment (mild/moderate, hemodialysis), CYP2D6 polymorphism, age over 60, and gender, with dosing recommendations related to these changes.*

FDA Label Image

Structure (A7f843b6 0935 4be6 A465 97179a846148 04)

Chemical structure of venlafaxine hydrochloride, showing the molecular arrangement including a cyclohexane ring, a methoxy-substituted aromatic ring, a hydroxyl group, and a dimethylamino group attached to the central carbon skeleton.*

FDA Label Image

Logo (A7f843b6 0935 4be6 A465 97179a846148 05)

FDA Label Image

Logo (A7f843b6 0935 4be6 A465 97179a846148 06)

FDA Label Image

Label Image (Lbl500903084)

Label for VENLAFAXINE HYDROCHLORIDE 37.5 MG capsules by A-S Medication Solutions. The label includes the NDC 50090-3084-0, product number 9127-0, storage instructions to store at 20 to 25 degrees C with 33 percent relative humidity, and notes that the capsules are unit dose and not for resale. Manufacturer information is Oceon Pharma Ltd, distributed by A-S Medication Solutions in Libertyville, IL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.